3D Systems Gains Additional FDA Clearance for DICOM-to-PRINT Software

3DD2P

3D Systems received additional FDA 510(k) clearance for its D2P™ (DICOM-to-PRINT) software for making 3D-printed diagnostic patient-specific anatomic models. 3D Systems is reportedly the only company to offer a combination of its own software and printers to create 3D models for diagnostic purposes for multiple medical specialties, including musculoskeletal applications. Anatomic models can be produced using ColorJet Printing, MultiJet Printing, Stereolithography and Selective Laser Sintering – including materials that are capable of sterility and biocompatibility.

Automatic segmentation tools driven by deep learning allow practitioners to create accurate models from medical imaging data. The additional FDA clearance addresses a growing demand from point of care institutions for in-house manufacturing using reliable 3D segmentation that can produce 3D-printed models.

Further, advancements in deep learning image processing and virtual reality visualization allow hospitals and device manufacturers to significantly reduce the time to create 3D models.

The software also includes a volumetric virtual reality solution to allow instant views of patient scans to assist with surgical planning.

“The capabilities offered in D2P give the healthcare professional an unprecedented toolset for deeper medical understanding across most medical specialties,” said Ran Bronstein, Vice President, Chief Research and Operation Officer at 3D Systems. “Our proprietary advanced visualization technology is changing how medical imaging data is used in a variety of formats such as virtual reality and 3D printed physical models.”

Source: 3D Systems

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE